![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: King D.J.
Publisher: Elsevier
ISSN: 0924-977X
Source: European Neuropsychopharmacology, Vol.8, Iss.1, 1998-02, pp. : 33-42
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Management of the Negative Symptoms of Schizophrenia: New Treatment Options
By Möller H-J.
CNS Drugs, Vol. 17, Iss. 11, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Add-on mirtazapine reduces negative schizophrenia symptoms
Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. :